138 related articles for article (PubMed ID: 37738654)
21. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
22. A Monte Carlo dose recalculation pipeline for durable datasets: an I-125 LDR prostate brachytherapy use case.
Ouellet S; Lemaréchal Y; Berumen-Murillo F; Lavallée MC; Vigneault É; Martin AG; Foster W; Thomson RM; Després P; Beaulieu L
Phys Med Biol; 2023 Nov; 68(23):. PubMed ID: 37863069
[TBL] [Abstract][Full Text] [Related]
23. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
24. Monte Carlo dosimetry for I125 and Pd103 eye plaque brachytherapy.
Thomson RM; Taylor REP; Rogers DWO
Med Phys; 2008 Dec; 35(12):5530-5543. PubMed ID: 28525130
[TBL] [Abstract][Full Text] [Related]
25. Measured, calculated, and egs_brachy I-125 dose distributions in a gold plaque for retinoblastoma treatment.
Trauernicht CJ; van Eeden D; du Plessis FCP
Med Phys; 2022 Sep; 49(9):6183-6194. PubMed ID: 35792659
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric study of the 15 mm ROPES eye plaque.
Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
[TBL] [Abstract][Full Text] [Related]
27. The effect of vaginal cylinder inhomogeneity on the HDR brachytherapy dose calculations using Monte Carlo simulations.
Meftahi M; Song WY
J Appl Clin Med Phys; 2024 Jan; 25(1):e14228. PubMed ID: 38043126
[TBL] [Abstract][Full Text] [Related]
28. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
29. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
[TBL] [Abstract][Full Text] [Related]
30. Initial evaluation of Advanced Collapsed cone Engine dose calculations in water medium for I-125 seeds and COMS eye plaques.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Mar; 45(3):1276-1286. PubMed ID: 29383721
[TBL] [Abstract][Full Text] [Related]
31. Generation and comparison of 3D dosimetric reference datasets for COMS eye plaque brachytherapy using model-based dose calculations.
Fletcher EM; Ballester F; Beaulieu L; Morrison H; Poher A; Rivard MJ; Sloboda RS; Vijande J; Thomson RM
Med Phys; 2024 Jan; 51(1):694-706. PubMed ID: 37665982
[TBL] [Abstract][Full Text] [Related]
32. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 16 mm OSU-Nag and COMS eye plaques.
Zhang H; Davidorf F; Qi Y
J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
[TBL] [Abstract][Full Text] [Related]
34. Update of the CLRP eye plaque brachytherapy database for photon-emitting sources.
Safigholi H; Parsons Z; Deering SG; Thomson RM
Med Phys; 2021 Jun; 48(6):3373-3283. PubMed ID: 33735471
[TBL] [Abstract][Full Text] [Related]
35. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
36. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
[TBL] [Abstract][Full Text] [Related]
37. Technical note: Monte Carlo derivation of TG-43 dosimetric parameters for radiation therapy resources and 3M Cs-137 sources.
Pérez-Calatayud J; Granero D; Ballester F; Casal E; Cases R; Agramunt S
Med Phys; 2005 Aug; 32(8):2464-70. PubMed ID: 16193775
[TBL] [Abstract][Full Text] [Related]
38. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
Poder J; Corde S
Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
[TBL] [Abstract][Full Text] [Related]
39. Experimental measurements and Monte Carlo calculations for (103)Pd dosimetry of the 12 mm COMS eye plaque.
Saidi P; Sadeghi M; Tenreiro C
Phys Med; 2013 May; 29(3):286-94. PubMed ID: 22592132
[TBL] [Abstract][Full Text] [Related]
40. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
